All News
The mixed conservative response to Trump’s health moves
And more health news stories you need to read.
Read MoreSTAT+: Pharmalittle: We’re reading about lower Wegovy prices, a dispute over Merck’s Keytruda, and more
Novo Nordisk plans to offer its Wegovy weight loss drug at a reduced cost of $499 per month for cash-paying customers in the U.S.
Read MoreCod Liver Oil for Measles; FDA, CDC Leases Terminated; Why Friday Surgery Is Risky
(MedPage Today) -- Note that some links may require registration or subscription. MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts.
Read MoreSTAT+: Jazz Pharmaceuticals to acquire Chimerix and its experimental brain cancer drug
Jazz Pharmaceuticals is spending nearly $1 billion to buy Chimerix and its experimental brain cancer drug
Read MoreHealthcare Plays a Minor Role in Trump's Address to Joint Session of Congress
(MedPage Today) -- Healthcare was something of a bit player in President Trump's address Tuesday night to a joint session of Congress.
Read MoreGenefitletics introduces Agegorithm to measure biological age at the molecular level
The machine learning-driven model analyses gut and oral microbiome functions to determine biological aging in comparison to chronological age
Read MoreExperts discuss obesity management strategies at National Conference in India
The Future of Obesity Care conference addressed India’s growing obesity crisis, highlighting multidisciplinary interventions and community-driven solutions
Read MoreWooden spoons are making us sick? I thought that was fish slices | Arwa Mahdawi
Another day, another health scare. I’m struggling to know which dangers I should take seriouslyIf you want to stir up online controversy, wooden spoons are the perfect tool with which to do so.
Read MoreSheffield researchers contribute to discovery of 69 new genes linked to rare diseases
A study using data from the 100,000 Genomes Project identified previously unknown genetic variants associated with rare diseases, including kidney disease and diabetes
Read MoreYears Later, Centene Settlements With States Still Unfinished
At least 20 states have settled disputes with health insurance giant Centene since 2021 over allegations that its pharmacy benefit manager operation overcharged their Medicaid programs.
Read More